Financials Diversified Healthcare Trust

Equities

DHC

US25525P1075

Specialized REITs

Market Closed - Nasdaq 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
2.43 USD +2.10% Intraday chart for Diversified Healthcare Trust +0.83% -35.03%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 2,008 981.7 738.5 155 899.3 572.2 - -
Enterprise Value (EV) 1 5,472 4,406 738.5 155 899.3 572.2 572.2 572.2
P/E ratio -22.8 x -6.98 x 4.23 x -9.24 x -3.04 x -2.27 x -3.13 x -
Yield 7.11% 4.37% 1.29% 6.18% 1.07% 1.68% 2.94% 8.4%
Capitalization / Revenue 1.93 x 0.6 x 0.53 x 0.12 x 0.64 x 0.38 x 0.36 x 0.34 x
EV / Revenue 1.93 x 0.6 x 0.53 x 0.12 x 0.64 x 0.38 x 0.36 x 0.34 x
EV / EBITDA 3.73 x 0.74 x 2.87 x 1.05 x 3.7 x 2.06 x 1.78 x 1.46 x
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Price to Book 0.73 x 0.39 x - - - - - -
Nbr of stocks (in thousands) 237,899 238,268 238,995 239,704 240,450 240,418 - -
Reference price 2 8.440 4.120 3.090 0.6468 3.740 2.380 2.380 2.380
Announcement Date 3/2/20 2/24/21 2/23/22 3/1/23 2/26/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1,040 1,632 1,383 1,284 1,410 1,515 1,610 1,700
EBITDA 1 538 1,331 257.3 148.1 242.8 277.9 321 390.7
EBIT 1 96.73 94.93 -31.15 -93.82 -103.3 -2.425 55.06 101.5
Operating Margin 9.3% 5.82% -2.25% -7.31% -7.32% -0.16% 3.42% 5.97%
Earnings before Tax (EBT) 1 -82.84 -133.1 181.4 -21.12 -272.7 -249.4 -184.8 -103.1
Net income 1 -88.23 -139.5 174.5 -15.77 -293.6 -267.7 -215.6 -94.1
Net margin -8.48% -8.54% 12.62% -1.23% -20.82% -17.67% -13.39% -5.54%
EPS 2 -0.3700 -0.5900 0.7300 -0.0700 -1.230 -1.050 -0.7600 -
Free Cash Flow - - - - - - - -
FCF margin - - - - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share 2 0.6000 0.1800 0.0400 0.0400 0.0400 0.0400 0.0700 0.2000
Announcement Date 3/2/20 2/24/21 2/23/22 3/1/23 2/26/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 337.4 336.7 310.7 313 322.9 336.9 346 346.2 356.5 361.5 370.6 374.1 381.5 388.5 394.7
EBITDA 1 59.36 54.47 33.78 47.98 35.78 45.96 53.98 62.14 58.81 59.19 63.57 66.17 71 77.2 76.6
EBIT 1 -9.337 -16.25 -23.48 -19.12 -33.05 -18.18 -16.74 -33.03 -20.93 -32.59 -6.235 -4.58 -0.056 8.445 -
Operating Margin -2.77% -4.83% -7.56% -6.11% -10.24% -5.4% -4.84% -9.54% -5.87% -9.01% -1.68% -1.22% -0.01% 2.17% -
Earnings before Tax (EBT) 1 -87.41 367.2 -89.25 -113.2 -83.61 -62.83 -53.28 -75.28 -65.44 -79.9 -66.79 -65.73 -61.54 -55.33 -52.1
Net income 1 -89.34 365.6 240.4 -109.4 -81.49 -65.32 -52.66 -72.57 -65.78 -102.6 -71.64 -70.61 -65.79 -59.71 -62.62
Net margin -26.48% 108.57% 77.37% -34.94% -25.24% -19.39% -15.22% -20.96% -18.45% -28.37% -19.33% -18.87% -17.25% -15.37% -15.86%
EPS 2 -0.3800 1.540 1.010 -0.4600 -0.3400 -0.2700 -0.2200 -0.3000 -0.2800 -0.4300 -0.2800 -0.2700 -0.2600 -0.2400 -0.2100
Dividend per Share 2 0.0100 0.0100 0.0100 0.0100 0.0100 0.0100 0.0100 0.0100 0.0100 0.0100 0.0100 0.0100 0.0100 0.0100 0.0100
Announcement Date 11/3/21 2/23/22 5/3/22 8/3/22 11/2/22 3/1/23 5/8/23 8/1/23 11/1/23 2/26/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 3,464 3,424 - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) 6.439 x 2.572 x - - - - - -
Free Cash Flow - - - - - - - -
ROE (net income / shareholders' equity) 1.45% -5.33% - - - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 11.50 10.50 - - - - - -
Cash Flow per Share 1.120 0.6700 -0.2700 -0.1700 - - - -
Capex - - - - - - - -
Capex / Sales - - - - - - - -
Announcement Date 3/2/20 2/24/21 2/23/22 3/1/23 2/26/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
2.43 USD
Average target price
3.5 USD
Spread / Average Target
+44.03%
Consensus
  1. Stock Market
  2. Equities
  3. DHC Stock
  4. Financials Diversified Healthcare Trust